Aimei Health Technology Co, LTD 8-K filings

Aimei Health Technology Co., Ltd. announced the termination of its business combination agreement with United Hydrogen Group Inc., citing the occurrence of the applicable outside date.

Aimei Health Technology Co., Ltd. has extended its business combination deadline by one month to August 6, 2026, with an associated extension payment and a new promissory note.

Aimei Health Technology Co., Ltd announced the resignation of director Julianne Huh and the appointment of Daniel Veikko Polvi to its board.

Aimei Health Technology Co., Ltd. has extended its business combination deadline to July 6, 2026, by depositing $34,330.96 and issuing a promissory note.

Aimei Health Technology Co., Ltd. has extended its business combination deadline by one month to June 6, 2026, through a $34,330.96 extension payment funded by a promissory note.

Aimei Health Technology Co., Ltd. has received a notice from Nasdaq for failing to file its annual report on time, risking delisting if compliance is not regained.

Aimei Health Technology Co., Ltd. has extended its business combination deadline by one month to May 6, 2026, through a $34,330.96 extension payment funded by a promissory note.

Aimei Health Technology Co., Ltd. extended its deadline to complete an initial business combination to March 6, 2026, funded by a $34,330.96 promissory note.

Aimei Health Technology Co., Ltd. extends its deadline to complete a business combination to February 6, 2026, funded by a $34,330.96 promissory note.

Aimei Health Technology Co., Ltd. secured a one-month extension for its initial business combination deadline to January 6, 2026, funded by a $34,330.96 promissory note.

Aimei Health Technology Co., Ltd. shareholders approved an extension for its business combination deadline and a revised trust account funding mechanism, amidst significant share redemptions.

Aimei Health Technology Co., Ltd. shareholders approved the definitive business combination agreement with United Hydrogen Global Inc. and related proposals at an extraordinary general meeting.

Aimei Health Technology Co., Ltd. extended its business combination deadline to December 6, 2025, via a $150,000 promissory note from its sponsor and United Hydrogen Group Inc.

Aimei Health Technology Co., Ltd. secures a one-month extension for its business combination deadline, funded by a $150,000 promissory note.

Aimei Health Technology Co., Ltd. has extended its deadline to complete an initial business combination to October 6, 2025, funded by a $150,000 promissory note from its Sponsor and United Hydrogen Group Inc.

Aimei Health Technology Co., Ltd. extended its deadline to complete an initial business combination by one month to September 6, 2025, funded by a $150,000 promissory note.

Aimei Health Technology Co., Ltd. has extended its deadline to complete an initial business combination by one month to August 6, 2025, funded by a $150,000 unsecured promissory note issued to its Sponsor and United Hydrogen Group Inc.

Aimei Health Technology Co., Ltd. and United Hydrogen Group Inc. have amended their Business Combination Agreement, extending the deadline for completing their merger to September 30, 2025.

Aimei Health Technology Co., Ltd. has announced a one-month extension to its business combination deadline, now set for July 6, 2025, funded by a $150,000 unsecured promissory note from its sponsor and target company.

Aimei Health Technology Co., Ltd secures a one-month extension to finalize its business combination by issuing a $150,000 promissory note.

Aimei Health Technology Co., Ltd extends its business combination deadline to May 6, 2025, funded by a $150,000 promissory note.

Aimei Health Technology Co., Ltd secures a one-month extension to finalize its initial business combination by obtaining $150,000 in funding via a promissory note.

Aimei Health Technology Co., Ltd. amended its trust agreement and issued a $150,000 promissory note to extend the deadline for its initial business combination.

Aimei Health Technology Co., Ltd postponed its extraordinary general meeting of shareholders due to a failure to achieve a quorum.

Aimei Health Technology Co., Ltd secures an extension to complete its initial business combination by issuing a promissory note for $227,700.

Aimei Health Technology Co., Ltd shareholders voted against proposals to amend the Investment Management Trust Agreement and to adjourn the Extraordinary General Meeting.

Aimei Health Technology Co., Ltd. has extended its deadline for a business combination by one month, funded by a $227,000 promissory note.

Aimei Health Technology Co., Ltd and United Hydrogen Group Inc. have entered into a definitive agreement for a business combination that will result in United Hydrogen becoming a publicly traded company on Nasdaq.

Aimei Health Technology Co., Ltd. has announced the resignation of its CEO, Juan Fernandez Pascual, and the appointment of Junheng Xie as the new CEO, effective April 15, 2024.

Aimei Health Technology Co., Ltd. announces that starting January 22, 2024, holders of its units can elect to separately trade the ordinary shares and rights included in those units.